LAURA STAWECKI: Open Payments
NPI 1629122346 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 33 payments from 13 companies in 2025. Trend: 2023 $1,378 · 2024 $875 · 2025 $632
Food & beverage: $612Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $86 |
| Boston Scientific Corporation | 2 | $75 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $51 |
| Kestra Medical Technology Services, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $42 |
| SCPHARMACEUTICALS INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: LEQVIO, LifeVest, WATCHMAN, REPATHA, Kerendia, Assure WCD, ELIQUIS, Ozempic.
Industry payments across LA — which companies pay providers there.
